| Poly (amino acids) as a potent self-adjuvanting delivery system for peptide-based nanovaccines M Skwarczynski, G Zhao, JC Boer, V Ozberk, A Azuar, JG Cruz, ... Science advances 6 (5), eaax2285, 2020 | 103 | 2020 |
| Dysfunctional survival-signaling and stress-intolerance in aged murine and human myocardium JN Peart, S Pepe, ME Reichelt, N Beckett, LS Hoe, V Ozberk, IR Niesman, ... Experimental gerontology 50, 72-81, 2014 | 70 | 2014 |
| Streptococcal immunity is constrained by lack of immunological memory following a single episode of pyoderma M Pandey, V Ozberk, A Calcutt, E Langshaw, J Powell, ... PLoS pathogens 12 (12), e1006122, 2016 | 42 | 2016 |
| Novel platform technology for modular mucosal vaccine that protects against streptococcus M Zaman, V Ozberk, EL Langshaw, V McPhun, JL Powell, ZN Phillips, ... Scientific reports 6 (1), 39274, 2016 | 38 | 2016 |
| Prime-pull immunization with a bivalent M-protein and spy-CEP peptide vaccine adjuvanted with CAF® 01 liposomes induces both mucosal and peripheral protection from covR/S … V Ozberk, S Reynolds, Y Huo, A Calcutt, S Eskandari, J Dooley, JL Mills, ... Mbio 12 (1), 10.1128/mbio. 03537-20, 2021 | 25 | 2021 |
| Ambient temperature stable, scalable COVID‐19 polymer particle vaccines induce protective immunity S Chen, B Evert, A Adeniyi, M Salla‐Martret, LHL Lua, V Ozberk, ... Advanced Healthcare Materials 11 (3), 2102089, 2022 | 20 | 2022 |
| Controlled infection immunization using delayed death drug treatment elicits protective immune responses to blood-stage malaria parasites LM Low, A Ssemaganda, XQ Liu, MF Ho, V Ozberk, J Fink, L Sundac, ... Infection and immunity 87 (1), 10.1128/iai. 00587-18, 2019 | 18 | 2019 |
| Preclinical safety and immunogenicity of Streptococcus pyogenes (Strep A) peptide vaccines S Reynolds, M Pandey, J Dooley, A Calcutt, M Batzloff, V Ozberk, JL Mills, ... Scientific reports 11 (1), 127, 2021 | 17 | 2021 |
| Antibodies to the conserved region of the M protein and a streptococcal superantigen cooperatively resolve toxic shock-like syndrome in HLA-humanized mice M Pandey, A Calcutt, V Ozberk, Z Chen, M Croxen, J Powell, E Langshaw, ... Science Advances 5 (9), eaax3013, 2019 | 17 | 2019 |
| Contribution of cryptic epitopes in designing a group A streptococcal vaccine V Ozberk, M Pandey, MF Good Human vaccines & immunotherapeutics 14 (8), 2034-2052, 2018 | 17 | 2018 |
| Antibodies to neutralising epitopes synergistically block the interaction of the receptor‐binding domain of SARS‐CoV‐2 to ACE 2 M Pandey, V Ozberk, S Eskandari, AO Shalash, MA Joyce, HA Saffran, ... Clinical & Translational Immunology 10 (3), e1260, 2021 | 16 | 2021 |
| Skin infection boosts memory B-cells specific for a cryptic vaccine epitope of group A streptococcus and broadens the immune response to enhance vaccine efficacy M Pandey, V Ozberk, EL Langshaw, A Calcutt, J Powell, MR Batzloff, ... npj Vaccines 3 (1), 15, 2018 | 15 | 2018 |
| Assembly of immunogenic protein particles toward advanced synthetic vaccines S Chen, DH Quan, G Sam, V Ozberk, XT Wang, P Halfmann, M Pandey, ... Small 19 (8), 2205819, 2023 | 11 | 2023 |
| Chronic β1-adrenoceptor blockade impairs ischaemic tolerance and preconditioning in murine myocardium LES Hoe, JM Schilling, AR Busija, KJ Haushalter, V Ozberk, ... European journal of pharmacology 789, 1-7, 2016 | 11 | 2016 |
| A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophils V Ozberk, M Zaman, A Lepletier, S Eskandari, J Kaden, JL Mills, A Calcutt, ... Nature Communications 14 (1), 5963, 2023 | 9 | 2023 |
| Pneumococcal phasevarions control multiple virulence traits, including vaccine candidate expression ZN Phillips, C Trappetti, A Van Den Bergh, G Martin, A Calcutt, V Ozberk, ... Microbiology Spectrum 10 (3), e00916-22, 2022 | 9 | 2022 |
| Polymeric epitope-based vaccine induces protective immunity against group A Streptococcus S Chen, V Ozberk, G Sam, ZJC Gonzaga, A Calcutt, M Pandey, MF Good, ... npj Vaccines 8 (1), 102, 2023 | 6 | 2023 |
| Streptolysin O Deficiency in Streptococcus pyogenes M1T1 covR/S Mutant Strain Attenuates Virulence in In Vitro and In Vivo Infection Models EL Langshaw, S Reynolds, V Ozberk, J Dooley, A Calcutt, M Zaman, ... Mbio 14 (1), e03488-22, 2023 | 5 | 2023 |
| Combinatorial liposomal peptide vaccine induces IgA and confers protection against influenza virus and bacterial super‐infection M Zaman, VC Huber, DL Heiden, KN DeHaan, S Chandra, D Erickson, ... Clinical & Translational Immunology 10 (9), e1337, 2021 | 5 | 2021 |
| Immunological characterisation of truncated lipooligosaccharide-outer membrane protein based conjugate vaccine against Moraxella catarrhalis and nontypeable Haemophilus influenzae S Singh, JC Wilson, AW Cripps, H Massa, V Ozberk, ID Grice, IR Peak Vaccine 38 (2), 309-317, 2020 | 5 | 2020 |
